Loading…
Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach
Background. This study evaluated the prognosis of patients with carcinoma in the gastric remnant stump after distal gastrectomy for benign disease (stump cancer). Methods. Twenty patients with resected stump cancer were studied and compared with 266 patients with resected primary cancer in the upper...
Saved in:
Published in: | Cancer 1994-01, Vol.73 (1), p.15-21 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c4735-1d5e4661d2f3e3300b31f85764d5405bc80b9e113bbf98bccbf932a01f60d7353 |
container_end_page | 21 |
container_issue | 1 |
container_start_page | 15 |
container_title | Cancer |
container_volume | 73 |
creator | Ikeguchi, Masahide Kondou, Akira Shibata, Shunsuke Yamashiro, Hiroshi Tsujitani, Shunichi Maeta, Michio Kaibara, Nobuaki |
description | Background. This study evaluated the prognosis of patients with carcinoma in the gastric remnant stump after distal gastrectomy for benign disease (stump cancer).
Methods. Twenty patients with resected stump cancer were studied and compared with 266 patients with resected primary cancer in the upper third of the stomach (primary cancer).
Results. The percentages of lymph nodes with metastases located at the lesser curvature and the left gastric artery, respectively, were 50.0% and 25.2% in patients with primary cancer and 15.0% and 5.0% in patients with stump cancer. In patients with remnant gastric cancer, lymph node metastases at jejunal mesentery near anastomotic site were found in 2 of 20 (10.0%).
Conclusion. The lymph flow from the remnant stomach seems to be changed by the initial operation, and as a result, in stump cancer, metastatic lymph nodes are located at different places from those associated with primary cancer. Even when curative surgery is performed in patients with stump cancer, it is important to follow up patients and check for possible metastasis to the liver.
The 5‐year survival rates were 62.1% and 52.5% for patients with curatively resected primary cancer (n = 203) and stump cancer (n = 17), respectively, and there was no statistical difference between the two groups. There was a distinct difference in terms of patterns of recurrence between patients with curatively resected primary cancer and those with stump cancer. The percentages of peritoneal and hematogenic metastases, respectively, were 40.6% and 31.3% in primary cancer and 0% and 83.3% in stump cancers. |
doi_str_mv | 10.1002/1097-0142(19940101)73:1<15::AID-CNCR2820730105>3.0.CO;2-J |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76328871</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76328871</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4735-1d5e4661d2f3e3300b31f85764d5405bc80b9e113bbf98bccbf932a01f60d7353</originalsourceid><addsrcrecordid>eNqVkV2LEzEUhgdR1rr6E4RciOjF1HxMmpmuCGX82mWxIAp6FTL5aCMzyZhkWPoL_Vum21pQQfDqkHOePDnhLYoVgnMEIX6BYMNKiCr8DDVNBRFEzxlZopeILpery9dl-6H9iGsMGckz-orM4bxdX-Dy6k4xO929W8wghHVJK_LlfvEgxm_5yDAlZ8VZjRmtEJsVP9reOiv9KNLW935jJVDWGB20kzqCTqcbrR2QIkjr_CCAdSBtNdiImEKGgx6ccAnENA0jECbpkAUxiR6MIiSb6y2qZfLDDhgfstPZjTu0vZq80i5TvY7WuwiEU2AMdhBh9_er0zhmf9raoIA3t62YvUJuHxb3jOijfnSs58Xnt28-te_L6_W7y3Z1XcqKEVoiRXW1WCCFDdGEQNgRZGrKFpWiFaSdrGHXaIRI15mm7qTMhWABkVlAlQXkvHh68I7Bf590THywUeq-F077KXK2ILiuGcrg1wMog48xaMOPv-II8n3IfB8U3wfFf4XMGeGII8p5Dpn_HjInHPJ2zTG_yu7HxyWmbtDqZD6mmudPjnMRpehNEE7aeMJI3WSIZEwdsBvb693_7PfP9f6YkJ-jzdYo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76328871</pqid></control><display><type>article</type><title>Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach</title><source>EZB Electronic Journals Library</source><creator>Ikeguchi, Masahide ; Kondou, Akira ; Shibata, Shunsuke ; Yamashiro, Hiroshi ; Tsujitani, Shunichi ; Maeta, Michio ; Kaibara, Nobuaki</creator><creatorcontrib>Ikeguchi, Masahide ; Kondou, Akira ; Shibata, Shunsuke ; Yamashiro, Hiroshi ; Tsujitani, Shunichi ; Maeta, Michio ; Kaibara, Nobuaki</creatorcontrib><description>Background. This study evaluated the prognosis of patients with carcinoma in the gastric remnant stump after distal gastrectomy for benign disease (stump cancer).
Methods. Twenty patients with resected stump cancer were studied and compared with 266 patients with resected primary cancer in the upper third of the stomach (primary cancer).
Results. The percentages of lymph nodes with metastases located at the lesser curvature and the left gastric artery, respectively, were 50.0% and 25.2% in patients with primary cancer and 15.0% and 5.0% in patients with stump cancer. In patients with remnant gastric cancer, lymph node metastases at jejunal mesentery near anastomotic site were found in 2 of 20 (10.0%).
Conclusion. The lymph flow from the remnant stomach seems to be changed by the initial operation, and as a result, in stump cancer, metastatic lymph nodes are located at different places from those associated with primary cancer. Even when curative surgery is performed in patients with stump cancer, it is important to follow up patients and check for possible metastasis to the liver.
The 5‐year survival rates were 62.1% and 52.5% for patients with curatively resected primary cancer (n = 203) and stump cancer (n = 17), respectively, and there was no statistical difference between the two groups. There was a distinct difference in terms of patterns of recurrence between patients with curatively resected primary cancer and those with stump cancer. The percentages of peritoneal and hematogenic metastases, respectively, were 40.6% and 31.3% in primary cancer and 0% and 83.3% in stump cancers.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19940101)73:1<15::AID-CNCR2820730105>3.0.CO;2-J</identifier><identifier>PMID: 8275417</identifier><identifier>CODEN: CANCAR</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Carcinoma - pathology ; Carcinoma - secondary ; Carcinoma - surgery ; carcinoma in the remnant stomach ; curative resection ; Duodenal Diseases - surgery ; Female ; Gastrectomy - methods ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Incidence ; Lymphatic Metastasis ; Male ; Medical sciences ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Neoplasm Staging ; primary carcinoma in the upper third of the stomach ; Prognosis ; Splenectomy ; Stomach Diseases - surgery ; Stomach Neoplasms - pathology ; Stomach Neoplasms - surgery ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Survival Rate ; Time Factors ; Tumors</subject><ispartof>Cancer, 1994-01, Vol.73 (1), p.15-21</ispartof><rights>Copyright © 1994 American Cancer Society</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4735-1d5e4661d2f3e3300b31f85764d5405bc80b9e113bbf98bccbf932a01f60d7353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3891733$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8275417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ikeguchi, Masahide</creatorcontrib><creatorcontrib>Kondou, Akira</creatorcontrib><creatorcontrib>Shibata, Shunsuke</creatorcontrib><creatorcontrib>Yamashiro, Hiroshi</creatorcontrib><creatorcontrib>Tsujitani, Shunichi</creatorcontrib><creatorcontrib>Maeta, Michio</creatorcontrib><creatorcontrib>Kaibara, Nobuaki</creatorcontrib><title>Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Background. This study evaluated the prognosis of patients with carcinoma in the gastric remnant stump after distal gastrectomy for benign disease (stump cancer).
Methods. Twenty patients with resected stump cancer were studied and compared with 266 patients with resected primary cancer in the upper third of the stomach (primary cancer).
Results. The percentages of lymph nodes with metastases located at the lesser curvature and the left gastric artery, respectively, were 50.0% and 25.2% in patients with primary cancer and 15.0% and 5.0% in patients with stump cancer. In patients with remnant gastric cancer, lymph node metastases at jejunal mesentery near anastomotic site were found in 2 of 20 (10.0%).
Conclusion. The lymph flow from the remnant stomach seems to be changed by the initial operation, and as a result, in stump cancer, metastatic lymph nodes are located at different places from those associated with primary cancer. Even when curative surgery is performed in patients with stump cancer, it is important to follow up patients and check for possible metastasis to the liver.
The 5‐year survival rates were 62.1% and 52.5% for patients with curatively resected primary cancer (n = 203) and stump cancer (n = 17), respectively, and there was no statistical difference between the two groups. There was a distinct difference in terms of patterns of recurrence between patients with curatively resected primary cancer and those with stump cancer. The percentages of peritoneal and hematogenic metastases, respectively, were 40.6% and 31.3% in primary cancer and 0% and 83.3% in stump cancers.</description><subject>Biological and medical sciences</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - secondary</subject><subject>Carcinoma - surgery</subject><subject>carcinoma in the remnant stomach</subject><subject>curative resection</subject><subject>Duodenal Diseases - surgery</subject><subject>Female</subject><subject>Gastrectomy - methods</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Incidence</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local</subject><subject>Neoplasm Staging</subject><subject>primary carcinoma in the upper third of the stomach</subject><subject>Prognosis</subject><subject>Splenectomy</subject><subject>Stomach Diseases - surgery</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - surgery</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Survival Rate</subject><subject>Time Factors</subject><subject>Tumors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNqVkV2LEzEUhgdR1rr6E4RciOjF1HxMmpmuCGX82mWxIAp6FTL5aCMzyZhkWPoL_Vum21pQQfDqkHOePDnhLYoVgnMEIX6BYMNKiCr8DDVNBRFEzxlZopeILpery9dl-6H9iGsMGckz-orM4bxdX-Dy6k4xO929W8wghHVJK_LlfvEgxm_5yDAlZ8VZjRmtEJsVP9reOiv9KNLW935jJVDWGB20kzqCTqcbrR2QIkjr_CCAdSBtNdiImEKGgx6ccAnENA0jECbpkAUxiR6MIiSb6y2qZfLDDhgfstPZjTu0vZq80i5TvY7WuwiEU2AMdhBh9_er0zhmf9raoIA3t62YvUJuHxb3jOijfnSs58Xnt28-te_L6_W7y3Z1XcqKEVoiRXW1WCCFDdGEQNgRZGrKFpWiFaSdrGHXaIRI15mm7qTMhWABkVlAlQXkvHh68I7Bf590THywUeq-F077KXK2ILiuGcrg1wMog48xaMOPv-II8n3IfB8U3wfFf4XMGeGII8p5Dpn_HjInHPJ2zTG_yu7HxyWmbtDqZD6mmudPjnMRpehNEE7aeMJI3WSIZEwdsBvb693_7PfP9f6YkJ-jzdYo</recordid><startdate>19940101</startdate><enddate>19940101</enddate><creator>Ikeguchi, Masahide</creator><creator>Kondou, Akira</creator><creator>Shibata, Shunsuke</creator><creator>Yamashiro, Hiroshi</creator><creator>Tsujitani, Shunichi</creator><creator>Maeta, Michio</creator><creator>Kaibara, Nobuaki</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940101</creationdate><title>Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach</title><author>Ikeguchi, Masahide ; Kondou, Akira ; Shibata, Shunsuke ; Yamashiro, Hiroshi ; Tsujitani, Shunichi ; Maeta, Michio ; Kaibara, Nobuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4735-1d5e4661d2f3e3300b31f85764d5405bc80b9e113bbf98bccbf932a01f60d7353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Biological and medical sciences</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - secondary</topic><topic>Carcinoma - surgery</topic><topic>carcinoma in the remnant stomach</topic><topic>curative resection</topic><topic>Duodenal Diseases - surgery</topic><topic>Female</topic><topic>Gastrectomy - methods</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Incidence</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local</topic><topic>Neoplasm Staging</topic><topic>primary carcinoma in the upper third of the stomach</topic><topic>Prognosis</topic><topic>Splenectomy</topic><topic>Stomach Diseases - surgery</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - surgery</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Survival Rate</topic><topic>Time Factors</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ikeguchi, Masahide</creatorcontrib><creatorcontrib>Kondou, Akira</creatorcontrib><creatorcontrib>Shibata, Shunsuke</creatorcontrib><creatorcontrib>Yamashiro, Hiroshi</creatorcontrib><creatorcontrib>Tsujitani, Shunichi</creatorcontrib><creatorcontrib>Maeta, Michio</creatorcontrib><creatorcontrib>Kaibara, Nobuaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ikeguchi, Masahide</au><au>Kondou, Akira</au><au>Shibata, Shunsuke</au><au>Yamashiro, Hiroshi</au><au>Tsujitani, Shunichi</au><au>Maeta, Michio</au><au>Kaibara, Nobuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1994-01-01</date><risdate>1994</risdate><volume>73</volume><issue>1</issue><spage>15</spage><epage>21</epage><pages>15-21</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><coden>CANCAR</coden><abstract>Background. This study evaluated the prognosis of patients with carcinoma in the gastric remnant stump after distal gastrectomy for benign disease (stump cancer).
Methods. Twenty patients with resected stump cancer were studied and compared with 266 patients with resected primary cancer in the upper third of the stomach (primary cancer).
Results. The percentages of lymph nodes with metastases located at the lesser curvature and the left gastric artery, respectively, were 50.0% and 25.2% in patients with primary cancer and 15.0% and 5.0% in patients with stump cancer. In patients with remnant gastric cancer, lymph node metastases at jejunal mesentery near anastomotic site were found in 2 of 20 (10.0%).
Conclusion. The lymph flow from the remnant stomach seems to be changed by the initial operation, and as a result, in stump cancer, metastatic lymph nodes are located at different places from those associated with primary cancer. Even when curative surgery is performed in patients with stump cancer, it is important to follow up patients and check for possible metastasis to the liver.
The 5‐year survival rates were 62.1% and 52.5% for patients with curatively resected primary cancer (n = 203) and stump cancer (n = 17), respectively, and there was no statistical difference between the two groups. There was a distinct difference in terms of patterns of recurrence between patients with curatively resected primary cancer and those with stump cancer. The percentages of peritoneal and hematogenic metastases, respectively, were 40.6% and 31.3% in primary cancer and 0% and 83.3% in stump cancers.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8275417</pmid><doi>10.1002/1097-0142(19940101)73:1<15::AID-CNCR2820730105>3.0.CO;2-J</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 1994-01, Vol.73 (1), p.15-21 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_76328871 |
source | EZB Electronic Journals Library |
subjects | Biological and medical sciences Carcinoma - pathology Carcinoma - secondary Carcinoma - surgery carcinoma in the remnant stomach curative resection Duodenal Diseases - surgery Female Gastrectomy - methods Gastroenterology. Liver. Pancreas. Abdomen Humans Incidence Lymphatic Metastasis Male Medical sciences Middle Aged Neoplasm Invasiveness Neoplasm Recurrence, Local Neoplasm Staging primary carcinoma in the upper third of the stomach Prognosis Splenectomy Stomach Diseases - surgery Stomach Neoplasms - pathology Stomach Neoplasms - surgery Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Survival Rate Time Factors Tumors |
title | Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A30%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinicopathologic%20differences%20between%20carcinoma%20in%20the%20gastric%20remnant%20stump%20after%20distal%20partial%20gastrectomy%20for%20benign%20gastroduodenal%20lesions%20and%20primary%20carcinoma%20in%20the%20upper%20third%20of%20the%20stomach&rft.jtitle=Cancer&rft.au=Ikeguchi,%20Masahide&rft.date=1994-01-01&rft.volume=73&rft.issue=1&rft.spage=15&rft.epage=21&rft.pages=15-21&rft.issn=0008-543X&rft.eissn=1097-0142&rft.coden=CANCAR&rft_id=info:doi/10.1002/1097-0142(19940101)73:1%3C15::AID-CNCR2820730105%3E3.0.CO;2-J&rft_dat=%3Cproquest_cross%3E76328871%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4735-1d5e4661d2f3e3300b31f85764d5405bc80b9e113bbf98bccbf932a01f60d7353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=76328871&rft_id=info:pmid/8275417&rfr_iscdi=true |